References
- SchellerDUllmerCBerkelsRGwarekMLübbertHThe in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson’s diseaseNaunyn Schmiedebergs Arch Pharmacol20093791738618704368
- SwartPJDe ZeeuwRAExtensive gastrointestinal metabolic conversion limits the oral bioavailability of the dopamine D2 agonist N-0923 in freely moving ratsPharmazie19924786136151359583
- CalabreseVPLloydKABrancazioPN-0923, a novel soluble dopamine D2 agonist in the treatment of parkinsonismMov Disord19981357687749756144
- AntoniniABernardiLCalandrellaDManciniFPlebaniMRotigotine transdermal patch in the management of Parkinson’s disease (PD) and its night-time use for PD-related sleep disordersFunct Neurol2010251212520626993
- GannuRPalemCRYamsaniVVYamsaniSKYamsaniMREnhanced bioavailability of lacidipine via microemulsion based transdermal gels: formulation optimization, ex vivo and in vivo characterizationInt J Pharm20103881–223124120060457
- SalimiASharif Makhmal ZadehBMoghimipourEPreparation and characterization of cyanocobalamin (vit B12) microemulsion properties and structure for topical and transdermal applicationIran J Basic Med Sci201316786587223997918
- ChenHChangXDuDLiJXuHYangXMicroemulsion-based hydrogel formulation of ibuprofen for topical deliveryInt J Pharm20063151–2525816600540
- LawrenceMJReesGDMicroemulsion-based media as novel drug delivery systemsAdv Drug Deliv Rev20004518912111104900
- ChenHMouDDuDHydrogel-thickened microemulsion for topical administration of drug molecule at an extremely low concentrationInt J Pharm20073411–2788417570625
- El-SherbinyIMYacoubMHHydrogel scaffolds for tissue engineering: Progress and challengesGlob Cardiol Sci Pract20132013331634224689032
- MoghimipourESalimiAKaramiMIsazadehSPreparation and characterization of dexamethasone microemulsion based on pseudoternary phase diagramJundishapur J Nat Pharm Prod20138310511224624198
- PanapisalVCharoensriSTantituvanontAFormulation of microemulsion systems for dermal delivery of silymarinAAPS Pharm Sci Tech2012132389399
- HaytonWLChenTCorrection of perfusate concentration for sample removalJ Pharm Sci19827178208217120072
- KommuruTRGurleyBKhanMAReddyIKSelf-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessmentInt J Pharm2001212223324611165081
- DelongeasJLde ConchardGVBeamonteAAssessment of Labrasol/Labrafil/Transcutol (4/4/2, v/v/v) as a non-clinical vehicle for poorly water-soluble compounds after 4-week oral toxicity study in Wistar ratsRegul Toxicol Pharmacol2010572–328429020347907
- ZhangYWangYWangZGOptimization of fermentation medium for the production of atrazine degrading strain Acinetobacter sp. DNS(32) by statistical analysis systemJ Biomed Biotechnol2012201262306223093851
- MahdiESSakeenaMHAbdulkarimMFAbdullahGZSattarMANoorAMEffect of surfactant and surfactant blends on pseudoternary phase diagram behavior of newly synthesized palm kernel oil estersDrug Des Devel Ther20115311323